1. Home
  2. INTJ vs PHGE Comparison

INTJ vs PHGE Comparison

Compare INTJ & PHGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTJ
  • PHGE
  • Stock Information
  • Founded
  • INTJ 2016
  • PHGE 2015
  • Country
  • INTJ Hong Kong
  • PHGE Israel
  • Employees
  • INTJ N/A
  • PHGE N/A
  • Industry
  • INTJ
  • PHGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • INTJ
  • PHGE Health Care
  • Exchange
  • INTJ NYSE
  • PHGE Nasdaq
  • Market Cap
  • INTJ 11.2M
  • PHGE 11.0M
  • IPO Year
  • INTJ 2024
  • PHGE N/A
  • Fundamental
  • Price
  • INTJ $1.22
  • PHGE $0.43
  • Analyst Decision
  • INTJ
  • PHGE Strong Buy
  • Analyst Count
  • INTJ 0
  • PHGE 1
  • Target Price
  • INTJ N/A
  • PHGE $15.00
  • AVG Volume (30 Days)
  • INTJ 238.2K
  • PHGE 3.1M
  • Earning Date
  • INTJ 08-01-2025
  • PHGE 08-13-2025
  • Dividend Yield
  • INTJ N/A
  • PHGE N/A
  • EPS Growth
  • INTJ N/A
  • PHGE N/A
  • EPS
  • INTJ N/A
  • PHGE N/A
  • Revenue
  • INTJ $2,607,186.00
  • PHGE N/A
  • Revenue This Year
  • INTJ N/A
  • PHGE N/A
  • Revenue Next Year
  • INTJ N/A
  • PHGE N/A
  • P/E Ratio
  • INTJ N/A
  • PHGE N/A
  • Revenue Growth
  • INTJ N/A
  • PHGE N/A
  • 52 Week Low
  • INTJ $0.48
  • PHGE $0.34
  • 52 Week High
  • INTJ $1.70
  • PHGE $2.35
  • Technical
  • Relative Strength Index (RSI)
  • INTJ N/A
  • PHGE 48.13
  • Support Level
  • INTJ N/A
  • PHGE $0.38
  • Resistance Level
  • INTJ N/A
  • PHGE $0.46
  • Average True Range (ATR)
  • INTJ 0.00
  • PHGE 0.05
  • MACD
  • INTJ 0.00
  • PHGE 0.01
  • Stochastic Oscillator
  • INTJ 0.00
  • PHGE 16.76

About INTJ INTELLIGENT GROUP LTD

Intelligent Group Ltd is a professional services provider in Hong Kong that principally engages in the provision of Financial PR services. The company provides a substantial number of holistic and comprehensive Financial PR services to its clients through its key operating entity in Hong Kong. It advises its clients on their communications and reputation management efforts. Its Financial PR services include creating multi-stakeholder communications programs, arranging press conferences and interviews, participating in the preparation of news releases and shareholders' meetings, monitoring news publications, identifying shareholders, targeting potential investors, organizing corporate events, and implementing crisis management policies and procedures.

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).

Share on Social Networks: